The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients

The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients - The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005068

Enrollment

Registered

2011-02-10

Start date

2010-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease and renal anemia

Interventions

Epoetin Darbepoetin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The concentration of Hb is under 11.0mg/dl in CKD patients

Exclusion criteria

Exclusion criteria: severe heart failure impossible control of hypertension and so on

Design outcomes

Primary

Measure	Time frame
The mean hemoglobin(Hb) change and the achievement rate of Hb target concentration	—

Secondary

Measure	Time frame
Iron kinetics	—

Countries

Japan

Contacts

Public ContactTakayasu Ito

Yamamoto general hospital Internal Medicine

takayassu@msn.com0594221211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026